WHO ICTRP trial
Effects of salt substitute on blood pressure among patients with early-stage…
ChiCTR2500100165 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100165 |
|---|---|
| Public title | Effects of salt substitute on blood pressure among patients with early-stage chronic kidney disease: a randomized controlled trial |
| Scientific title | Effects of salt substitute on blood pressure among patients with early-stage chronic kidney disease: a randomized controlled trial - ECLIPSE-CKD |
| Primary sponsor | School of Public Health, Harbin Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | early-stage chronic kidney disease |
| Interventions | Intervention group:Participants in the intervention group will receive salt substitute (75% sodium chloride, 25% potassium chloride) free of charge to replace regular salt (nearly 100% sodium chloride) for 3 months;Control… |
| Registration date | Apr 3, 2025 |
| Target size | Intervention group:317;Control group:317 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: